Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 12 matching records.
12 results — page 1 of 1
- Level BClinical TrialEurope PMC
Mesenchymal stem cells and the central nervous system: historical perspectives and future directions
Clinical Trial on Disc Degeneration, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Front Mol Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
Front Mol Neurosci1 citations - Level DLaboratory StudyPubMed
Single-Cell Landscapes of Adipose-Derived Mesenchymal Stem Cells: From Homeostatic Regulators to Obesity-Driven Central Hubs.
Laboratory Study on Chronic Inflammation, published in Endocr Rev (2026) — summary generated from the PubMed abstract.
- 2026
Endocr Rev - Level DNarrative ReviewEurope PMC
Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair
Narrative Review on Neuroinflammation, Immune Modulation, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol1 citations - Level CProspective StudyEurope PMC
Exosomal miR-23a-3p derived from human umbilical cord mesenchymal stem cells promotes remyelination in central nervous system demyelinating diseases by targeting Tbr1/Wnt pathway
Prospective Study on Neuroinflammation, Autoimmune Research, published in J Biol Chem (2024) — summary generated from the PubMed abstract.
- 2024
J Biol Chem10 citations - Level DAnimal StudyPubMed
Adipose mesenchymal stem cells-derived extracellular vesicles exert their preferential action in damaged central sites of SOD1 mice rather than peripherally.
Animal Study on Neuroinflammation, published in Eur J Histochem (2024) — summary generated from the PubMed abstract.
- 2024
Eur J Histochem4 citations - Level DAnimal StudyPubMed
Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach.
Animal Study on Immune Modulation, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther24 citations - Level AMeta-analysisPubMed
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 52 on Spinal Cord Injury, published in Neural Regen Res (2023) — summary generated from the PubMed abstract.
- 2023
- n = 52
Neural Regen Res - Level BClinical TrialPubMed
Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders.
Clinical Trial on Neuroinflammation, Chronic Inflammation, published in Pharmaceutics (2023) — summary generated from the PubMed abstract.
- 2023
Pharmaceutics17 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cells for regenerative medicine in central nervous system
Narrative Review on Spinal Cord Injury, Neuroinflammation, Immune Modulation, published in Front Neurosci (2022) — summary generated from the PubMed abstract.
- 2022
Front Neurosci25 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration
Narrative Review, published in Int J Nanomedicine (2019) — summary generated from the PubMed abstract.
- 2019
Int J Nanomedicine28 citations - Level DAnimal StudyPubMed
Electroacupuncture Promotes Central Nervous System-Dependent Release of Mesenchymal Stem Cells.
Animal Study on Tendon Injury, Chronic Inflammation, published in Stem Cells (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cells43 citations - Level DAnimal StudyPubMed
Mouse white adipose tissue-derived mesenchymal stem cells gain pericentral and periportal hepatocyte features after differentiation in vitro, which are preserved in vivo after hepatic transplantation.
Animal Study, published in Acta Physiol (Oxf) (2015) — summary generated from the PubMed abstract.
- 2015
Acta Physiol (Oxf)
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406